61919-0545 Ondansetron

Product NDC:

61919-0545

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 61919-0545-05

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (61919-545-05)

Effective Date: Jan. 1, 2014

Discontinued:

Code: 61919-0545-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (61919-545-06)

Effective Date: Jan. 1, 2014

Discontinued:

Code: 61919-0545-10

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (61919-545-10)

Effective Date: Dec. 1, 2015

Discontinued:

Code: 61919-0545-30

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (61919-545-30)

Effective Date: Jan. 1, 2015

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox